PROCEPT BioRobotics (PRCT) Short term Debt (2020)

PROCEPT BioRobotics' (PRCT) quarterly Short term Debt came in at $4.6 million in Q4 2020.

PROCEPT BioRobotics (PRCT) Short term Debt (2020) Analysis & Trends

PROCEPT BioRobotics (PRCT) has 1 years of Short term Debt data on file, last reported at $4.6 million in Q4 2020.

  • On a quarterly basis, Short term Debt changed N/A year-over-year to $4.6 million in Q4 2020; TTM through Dec 2020 was $4.6 million, a N/A change from a year earlier, with the FY2020 full-year figure at $4.6 million, changed N/A from the prior year.
  • Short term Debt for Q4 2020 stood at $4.6 million.
  • Over the last five years, Short term Debt for PRCT reached as high as $4.6 million in Q4 2020 and fell as low as $4.6 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.03 Bn 6.27 Bn
2 Stryker 128.82 Bn 125.95 Bn 3.81 Bn
3 Medtronic 108.46 Bn 99.24 Bn 6.41 Bn
4 Boston Scientific 68.25 Bn 66.79 Bn 3.61 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn
6 Dexcom 28.55 Bn 27.43 Bn 750.30 Mn
7 GE HealthCare Technologies 28.51 Bn 26.22 Bn 1.98 Bn
8 Smith & Nephew 26.96 Bn 26.39 Bn -
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn
10 PROCEPT BioRobotics 994.59 Mn 748.95 Mn 53.95 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 4.55 Mn